Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial
2016 · The Lancet · 518 citations
https://doi.org/10.1016/s0140-6736(16)30956-4
D
David Cooper
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
2.6K
Citations
24
h-index
47
i10-index
David Cooper is an academic researcher from University of Aberdeen. The author has contributed to research in topics: Pelvic floor disorders treatments & Microbial Natural Products and Biosynthesis & Urinary Bladder and Prostate Research. The author has an h-index of 24, co-authored 99 publications.
ORCID: 0000-0002-9361-4399Papers by this author
worksBariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018 · Health Technology Assessment · 100 citations
https://doi.org/10.3310/hta22680
Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men with Urodynamic Stress Incontinence After Prostate Surgery (MASTER)
2021 · European Urology · 94 citations
https://doi.org/10.1016/j.eururo.2021.01.024
Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis
2021 · PLoS Medicine · 51 citations
https://doi.org/10.1371/journal.pmed.1003506
Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms
2021 · Trials · 18 citations
https://doi.org/10.1186/s13063-021-05661-3
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial
2025 · The Lancet · 17 citations
https://doi.org/10.1016/s0140-6736(24)01886-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat